TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Bioform AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
24,061
|
21,268
|
11,852 |
| Financial expenses |
240
|
137
|
131 |
| Earnings before taxes |
9,373
|
8,664
|
759 |
| Total assets |
32,618
|
20,654
|
16,480 |
| Current assets |
24,657
|
17,113
|
14,120 |
| Current liabilities |
4,920
|
2,059
|
4,902 |
| Equity capital |
25,698
|
18,595
|
11,579 |
| - share capital |
700
|
700
|
700 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.8%
|
90.0%
|
70.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
39.0%
|
40.7%
|
6.4% |
| Return on assets (ROA) |
29.5%
|
42.6%
|
5.4% |
| Current ratio |
501.2%
|
831.1%
|
288.0% |
| Return on equity (ROE) |
36.5%
|
46.6%
|
6.6% |
| Change turnover |
2,793
|
9,416
|
-2,813 |
| Change turnover % |
13%
|
79%
|
-19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.